Sun Pharmaceutical Industries Share Price Today - Live Blog for June 10, 2025

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.06%, signalling a challenging period. Currently trading at ₹1,689.45, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Following a noteworthy 0.17% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,691.10. When it comes to valuation, this stock has a PE ratio of 37.2000, with the industry PE ratio at 34.1655.

Following a noteworthy 0.12% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,688.20. When it comes to valuation, this stock has a PE ratio of 37.2000, with the industry PE ratio at 34.1655.

The stock of Sun Pharmaceutical Industries Ltd is facing a -0.07% decline and is currently trading at ₹1,686.85 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Investors are buzzing as Sun Pharmaceutical Industries Ltd's share price soared by an impressive 0.15%. At this moment, it's actively trading at ₹1,689.60, presenting an enticing opportunity for those in the market.

Sun Pharmaceutical Industries Ltd experienced a -0.25% downturn in its share price, and it's currently trading at ₹1,687.95. This situation is generating interest among value investors who are evaluating the stock's potential.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.17%, reaching the current market price of ₹1,691.05. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd displayed price stability, with no changes, and is trading at ₹1,686.85. This sustained performance invites investors to assess whether the stock aligns with their long-term investment goals.

Climbing steadily, Sun Pharmaceutical Industries Ltd shares have ascended by 0.21%, reaching the current market price of ₹1,685.30. This ascent signifies increased investor sentiment. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

After a notable 0.04% increase, Sun Pharmaceutical Industries Ltd's shares are now trading at ₹1,682.05. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.0327 and an ROE of 15.1334%.

The share price of Sun Pharmaceutical Industries Ltd plunged by -0.07%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,681.50, but investors are assessing whether this is a temporary dip or a long-term trend.

Sun Pharmaceutical Industries Ltd witnessed a notable 0.02% surge in its share price and is presently trading at ₹1,682.40, captivating the attention of market participants.

The share price of Sun Pharmaceutical Industries Ltd experienced an impressive 0.10% upswing and is currently trading at ₹1,680.60, indicating strong market sentiment.

Sun Pharmaceutical Industries Ltd observed a -0.22% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,679.00. The stock has a PE ratio of 37.2000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

Sun Pharmaceutical Industries Ltd's share price has dropped by -0.14%, a development that warrants careful analysis. Presently trading at ₹1,682.00, investors are assessing whether this presents an opportunity or a risk.

The stock price of Sun Pharmaceutical Industries Ltd enjoyed a significant 0.05% boost, with the current market value at ₹1,682.90 per share. This surge has not gone unnoticed by investors.

Sun Pharmaceutical Industries Ltd witnessed a -0.08% decrease in its share price, and it is currently trading at ₹1,682.15. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 37.2000, an ROE of 15.1334% and a debt to equity ratio of 0.0327.

With a -0.14% decrease, Sun Pharmaceutical Industries Ltd's share price is now at ₹1,683.25. The stock is currently trading at a PE of 37.2000, while the industry PE is 34.1655, prompting investors to assess its value proposition.

The stock of Sun Pharmaceutical Industries Ltd suffered a -0.01% drop, and it's now trading at ₹1,684.25 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

In recent times, Sun Pharmaceutical Industries Ltd witnessed a decline of -0.10% in its share price, and it currently trades at ₹1,684.30 per share. The stock has an ROE of 15.1334% and debt to equity ratio of 0.0327.

The share price of Sun Pharmaceutical Industries Ltd experienced a -0.26% slump and is currently trading at ₹1,686.70. While the stock maintains a PE ratio of 37.2000, the industry PE is 34.1655, raising questions about valuation.

Sun Pharmaceutical Industries Ltd shares saw a decrease of -0.26%, reaching a current market price of ₹1,691.15. Investors are evaluating the impact of this decline on the stock's overall performance and attractiveness.

Sun Pharmaceutical Industries Ltd share price surged by 0.11%. With its current market price standing at ₹1,694.80 per share, this stock is garnering increased attention from the investment community.

Sun Pharmaceutical Industries Ltd's stock has surged by 0.13%, and it is currently trading at ₹1,693.00. Additionally, the stock maintains a PE ratio of 37.2000, while the industry PE is 34.1655.

The share price of Sun Pharmaceutical Industries Ltd has plummeted by -0.32%, signalling a challenging period. Currently trading at ₹1,691.65, this stock has caught the eye of bargain hunters, who may be considering their entry points.

The stock of Sun Pharmaceutical Industries Ltd is making significant strides, boasting a 0.16% increase and currently trading at ₹1,697.00 per share. This upward trajectory is turning heads in the market.